Literature DB >> 30306583

Cancer of the vulva.

Linda J Rogers1,2, Mauricio A Cuello3.   

Abstract

Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. There is no specific screening and the most effective strategy to reduce vulvar cancer incidence is the opportune treatment of predisposing and preneoplastic lesions associated with its development. While vulvar cancer may be asymptomatic, most women present with vulvar pruritus or pain, or have noticed a lump or ulcer. Therefore, any suspicious vulvar lesion should be biopsied to exclude invasion. Once established, the most common subtype is squamous cell carcinoma. Treatment of vulvar cancer depends primarily on histology and surgical staging. Treatment is predominantly surgical, particularly for squamous cell carcinoma, although concurrent chemoradiation is an effective alternative, particularly for advanced tumors. Management should be individualized, and carried out by a multidisciplinary team in a cancer center experienced in the treatment of these tumors.
© 2018 The Authors. International Journal of Gynecology & Obstetrics published by John Wiley & Sons Ltd on behalf of International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Cancer staging; Chemotherapy; Diagnostic imaging; FIGO Cancer Report; Radiotherapy; Risk factors; Surgery; Therapy; Vulvar cancer; Vulvar neoplasms

Mesh:

Year:  2018        PMID: 30306583     DOI: 10.1002/ijgo.12609

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  20 in total

Review 1.  A Brief Overview of Oncogenes and Signal Transduction Pathways in Gynecological Cancer.

Authors:  Emmanuel N Kontomanolis; Antonios Koutras; Zacharias Fasoulakis; Athanasios Syllaios; Michail Diakosavvas; Kyveli Angelou; Panagiotis Symeonidis; Athina A Samara; Vasilios Pergialiotis; Nikolaos Garmpis; Dimitrios Schizas; Athanasios Pagkalos; Athanasios Chionis; Georgios Daskalakis; Thomas Ntounis
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  Human Papillomavirus‒Positive and ‒Negative Vulvar Squamous Cell Carcinoma Are Biologically but Not Clinically Distinct.

Authors:  Elysha Kolitz; Elena Lucas; Gregory A Hosler; Jiwoong Kim; Suntrea Hammer; Cheryl Lewis; Lin Xu; Andrew T Day; Melissa Mauskar; Jayanthi S Lea; Richard C Wang
Journal:  J Invest Dermatol       Date:  2021-10-28       Impact factor: 7.590

3.  Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status.

Authors:  Tjalling Bosse; Lynn N Hoang; Basile Tessier-Cloutier; Kim E Kortekaas; Emily Thompson; Jennifer Pors; Julia Chen; Julie Ho; Leah M Prentice; Melissa K McConechy; Christine Chow; Lily Proctor; Jessica N McAlpine; David G Huntsman; C Blake Gilks
Journal:  Mod Pathol       Date:  2020-03-20       Impact factor: 7.842

4.  Risk Factors for Postoperative Complications After Vulvar Surgery.

Authors:  Nicolae Bacalbasa; Irina Balescu; Mihaela Vilcu; Simona Dima; Iulian Brezean
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

5.  Perineural Invasion in Vulvar Squamous-Cell Carcinoma Is an Independent Risk Factor for Cancer-Specific Survival, but Not for Locoregional Recurrence: Results from a Single Tertiary Referral Center.

Authors:  Leonardo Micheletti; Fulvio Borella; Mario Preti; Valentina Frau; Stefano Cosma; Sebastiana Privitera; Luca Bertero; Chiara Benedetto
Journal:  Cancers (Basel)       Date:  2021-12-28       Impact factor: 6.639

6.  Deep learning for the standardized classification of Ki-67 in vulva carcinoma: A feasibility study.

Authors:  Matthias Choschzick; Mariam Alyahiaoui; Alexander Ciritsis; Cristina Rossi; André Gut; Patryk Hejduk; Andreas Boss
Journal:  Heliyon       Date:  2021-07-15

7.  Impact of a delayed diagnosis of vulvar cancer and its association with HIV infection: A 4-year review at a tertiary hospital in KwaZulu-Natal, South Africa.

Authors:  Ramakhosana S Hlapane; Thandekile L Khumalo; Bongumusa S Makhathini; Jagidesa Moodley
Journal:  South Afr J HIV Med       Date:  2021-09-08       Impact factor: 2.744

8.  Assessment of TSPAN Expression Profile and Their Role in the VSCC Prognosis.

Authors:  Kelly Pedrozo Ferreira; Bruna Cristine de Almeida; Laura Gonzalez Dos Anjos; Glauco Baiocchi; Fernando Augusto Soares; Rafael Malagoli Rocha; Edmund Chada Baracat; Andrey Senos Dobroff; Katia Candido Carvalho
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

9.  Comparison of two types of the triple incision technique in the treatment of patients with locally advanced vulvar cancer.

Authors:  Ying Ma; Wei-Feng Liang; Chang-Hao Liu; Zhong-Qiu Lin; Miao-Fang Wu; Jing Li
Journal:  Int J Med Sci       Date:  2020-09-16       Impact factor: 3.738

10.  Radical vulvectomy with right gluteal and left medial thigh V-Y advancement flap reconstruction

Authors:  İlker Selçuk; Ozan Doğan; Cağatay Barut; Eray Çalışkan; Kamil Zalewski; Evrim Erdemoğlu; Ate van der Zee
Journal:  J Turk Ger Gynecol Assoc       Date:  2020-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.